Posted on

Beyond the Hype: A Strategic Blueprint for AI Investment in 2025 and Beyond

4 min read

AI Investment in 2025Artificial intelligence (AI) is one of the most talked-about technologies today. It has taken a shift from the broad general-purpose tools to specialized innovations that promise real impact. AI is dominating headlines with investor pitches. There has also been a surge in startups promising AI-powered solutions. However, some businesses have already adopted and invested millions into AI projects with little return. As AI advances, business owners and investors need to stop chasing the latest headlines and consider how to best integrate AI to create lasting value.

Understanding the AI Investment Landscape in 2025

Since the AI breakout, it has advanced dramatically. There are three forces that are reshaping the investment and adoption of AI.

  1. Maturation of Foundation Models
    The large language models (LLMs) are now cheaper and faster. They are also customizable. This means that businesses no longer need to build from scratch and can just adapt existing models in their industry.
  2. Regulations and Accountability
    Governments are tightening frameworks around data privacy, transparency, and responsible AI. Compliance has become a key competitive differentiator.
  3. Sector-Specific Applications
    Advancements in AI have given way to specialized use cases. For example, fintech AI can track fraud, while manufacturing AI optimizes the supply chain.

The AI Hype Cycle

According to Gartner’s 2025 “Hype Cycle for Artificial Intelligence.” AI technologies move through predictable stages. These include the innovation trigger, peak of inflated expectations, trough of disillusionment, slope of enlightenment, and plateau of productivity. Between 2023 and 2024, generative AI dominated the headlines. It has now entered the trough of disillusionment as organizations confront their limitations, governance risks, and the difficulty of proving ROI. However, this is not to be seen as a setback, but rather a turning point as businesses shift focus from experimentation to scaling reasonably. Investment is now focused on foundational enablers such as ready data, ModelOps for lifecycle management, and AI agents. By 2025, businesses will be realizing that quick wins are harder than expected. On the bright side, businesses have an opportunity to build sustainable systems that offer measurable business value.

Lessons Learned from the First Wave of AI Adoption

The promises that came with AI led some businesses to invest heavily. This resulted in several mistakes:

  • Chasing innovation over value
    Many businesses rushed to invest in AI-powered projects like chatbots without linking them to actual business goals. For instance, customers have raised concerns about frustration with bank AI bots that confuse rather than help customers, according to the Consumer Financial Protection Bureau (CFPB).
  • Falling for AI hype
    Some businesses invested in companies branding themselves as AI-driven, even when the solutions offered relied on basic automation.
  • Ignoring integration
    Failing to consider that AI is not a plug-and-play solution. This saw some early adopters underestimating the cultural, technical, and operational changes required to integrate AI into workflows.

A Strategic Blueprint for AI Investment

For businesses to invest wisely:

  1. Start with the problem, not the tool
    Instead of shopping for tools to adopt, a business should first ponder what problem it wants to solve. This means clearly defining the problem to solve, such as personalizing marketing campaigns or predicting supply shortages. Clarifying a problem ensures the AI investment is focused and not an experiment.
  2. Build a portfolio approach
    Borrowing from how investors diversify portfolios, a business should also diversify its AI initiatives. They can do this by balancing short-term projects, such as automating repetitive tasks, with long-term projects like predictive analytics. This is to ensure there is a steady return on investment.
  3. Prioritize responsible and compliant AI
    Reputation is crucial, and businesses should avoid mishandling customer data. To do this, companies must invest in compliance, transparency, and explainability as part of their AI strategy.
  4. Invest in people, not just technology
    AI does not replace talent. Companies should invest in training and upskilling their workforce. This prepares employees to work well with the new technology to ensure adoption is smooth and effective.
  5. Build scalable infrastructure
    Even with the most advanced AI model, failing to have the right foundation will result in unsuccessful implementation. The lesson? Companies must invest in flexible systems that can grow with them.

Conclusion

AI is no longer a futuristic concept. It is a business reality. Adopting AI alone is not enough, and businesses need to do it wisely. Businesses should refrain from jumping on the latest trends. Instead, make strategic choices that align with long-term goals. The focus should be on the problems to be solved and not the tools. 

Posted on

Canceling Government Funding and Expanding Protections for Veterans

3 min read

hr 4, hr 517, hr1316, s 423, hr1815, s 264, s201Rescissions Act of 2025 (HR 4) – A rescission bill cancels funding previously approved by Congress upon request by the president. Congress has 45 continuous legislative days to enact or reject the proposal, during which time the funds may be temporarily withheld. Introduced by Rep. Steve Scalise (R-LA) on June 6, the House passed this bill on June 12 and the Senate passed it on July 17. Signed into law on July 24, this bill cancels nearly $9 billion in funding for a variety of programs, including foreign aid and the Corporation for Public Broadcasting.

Filing Relief for Natural Disasters Act (HR 517) – On July 24, the president signed into law this bill that allows taxpayers to postpone their filings if their state governor has declared a natural disaster, rather than waiting for the president to declare a federal disaster. The bill was introduced by Rep. David Kustoff on Jan. 16, passed in the House on March 31 and in the Senate on July 10.

Maintaining American Superiority by Improving Export Control Transparency Act (HR 1316) – Introduced by Rep. Ronny Jackson (R-TX) on Feb. 13, this legislation is designed to crack down on U.S. adversaries acquiring cutting-edge technology. The bill mandates that the Secretary of Commerce submit an annual report to Congress detailing dual-use export license applications and other requests for authorization for the export, re-export, release and in-country transfer of controlled items to arms-embargoed countries such as China, Russia, Iran and North Korea. The legislation was passed in the House on May 5, the Senate on May 22 and was signed into law on Aug. 19.

PRO Veterans Act of 2025 (S 423) – The purpose of this act is to prevent fraud and abuse via increased oversight of the Veterans Affairs Department, including critical skill bonuses paid out to senior executives. Moreover, the bill requires quarterly, in-person briefings to congressional veterans’ committees regarding VA departmental budget shortfalls. The legislation was introduced by Sen. Dan Sullivan (R-AK) on Feb. 5, passed in the Senate on April 8 and in the House on July 21. The bill was enacted on Aug. 19.

VA Home Loan Program Reform Act (HR 1815) – This bill was introduced on March 3 by Rep. Derrick Van Orden (R-WI), passed in the House on May 19, the Senate on July 15, and signed into law on July 30. The law reauthorizes the VA home loan partial claim and Veterans Affairs Servicing Purchase (VASP) programs. These programs are designed to help distressed veteran homeowners avoid foreclosure by enabling the VA to purchase a portion of indebtedness (25 percent to 30 percent of the unpaid principal balance) of a VA home loan secured by the primary residence of the borrower.

Improving Veterans’ Experience Act of 2025 (S 264) – This bill is meant to improve satisfaction with VA benefits and services by compiling feedback from veterans, families and caregivers. This legislation establishes a Veterans Experience Office (VEO) to manage customer experience initiatives, collect data and coordinate VA departments in order to prevent duplicate efforts and ensure consistent improvements across the board. The bill was introduced on Jan. 28 by Sen. Angus King (I-ME), passed in the Senate on April 8, the House on July 21 and was enacted on Aug. 14.

ACES Act of 2025 (S 201) – This act was introduced by Sen. Mark Kelly (D-AZ) on Jan. 23. It directs the secretary of the VA to study cancer and mortality rates among aviators and aircrews who served in the Navy, Air Force and Marine Corps; and to correlate incidents of cancer among this select group of military personnel. The legislation passed in the Senate on June 3, the House on July 21, and was signed by the president on Aug. 14.

Posted on

Capitalizing Versus Expensing Research and Development

4 min read

Capitalizing Versus Expensing Research and DevelopmentBased on statistics from the World Bank, the United States government spent 3.59 percent of its 2022 gross domestic product on research and development. While private businesses spend on their own research and development costs, it’s important for businesses to treat these expenditures appropriately.

When it comes to research and development outlays, U.S. Generally Accepted Accounting Principles (GAAP) dictate that businesses must expense them during the identical fiscal year as they’re consumed. Accordingly, this creates difficulties for investors and business owners alike in two ways. The first is more uncertain profitability and loss projections. The second is a murkier ability to quantify their rates of return on assets and investments.  

If R&D capitalization is minimal or non-existent by a company, it can imply the business’ total assets (or its total invested capital) doesn’t accurately represent how much has been put into such assets. This will affect the business’ Return on Assets (ROA) and Return on Invested Capital (ROIC). This illustrates the importance in differences of how businesses treat their R&D expenses – using the balance sheet to capitalize and the income statement to expense.

Accounting Standards

Per International Financial Reporting Standards (IFRS), research outlays are classified as expenses annually, like GAAP. However, development costs may be capitalized for businesses with assets under incubation for saleable purposes (in other words, the tech/IP is expected to be approved and produce revenue in the future).

One consideration with IFRS is that a portion of research and development costs may be capitalized or recorded as an asset on the business’ balance sheet, instead of classified as an expense on the Profit and Loss Statement. It’s important, though, to understand that judgment is in the eye of the classification as to how commercially viable a product or service will be in the future, potentially causing issues on the company’s financial statements. Since research and development is sporadic, it impacts a business’ profitability. It’s seen in certain sectors, such as consumer discretionary, healthcare, and technology, to highlight a few.

With revenue, cash flow, and profit expected from the long-term investment of research and development, for products or services with a realistic chance, it should be capitalized and not expensed. Investors need to be aware of the differences in how businesses capitalize or expense their research and development spending, since, without additional financial analysis, it’s important to factor in research and development equally. This is because companies that don’t capitalize experience more unstable earnings.

Exploring Capitalization Versus Expensing

To determine the value and to capitalize such assets, analysts must project the asset’s lifespan to produce benefits (over its economic life) and go with that projection for the amortization period.

Amortization life varies between assets and is based on the economic life of the particular asset. Ways to determine the economic life depend on both the asset’s patentability and/or salability. If there’s a pharmaceutical drug with a 20-year patent, it’ll likely have a much longer life than the next mobile device or graphic processing unit (GPU).

Assuming an asset has a life of six years, the business would amortize equally over the six-year time frame. There can be a multitude of amortization approaches, but the straight-line method is used for the capitalized research and development expenses. It assumes the following figures:

$200,000 spent on R&D

$40,000 residual value

Based on the difference of $160,000 and the six-year economic life, each year would result in approximately $26,666 in amortization expense. After six years, the resulting value would be $40,000 in residual value.

Conclusion

Understanding the importance of accounting for R&D outlays is helpful for businesses to maximize investments for competitiveness and financial compliance.